Telehealth

A new campaign reveals a public health crisis of 'eye anxiety.' But behind the celebrity endorsement lies a sharp strategy to vertically integrate and capture the market.

A Las Vegas clinic offers a specialized program for first responders battling trauma and addiction. But does it address the systemic crisis facing our heroes?

A new AI tool scores meals on insulin impact, not calories. Can this data-driven approach disrupt the wellness market where others have stalled?

As healthcare rushes to adopt AI, a young company's award win spotlights the critical, multi-billion dollar race to ensure innovation doesn't outpace safety.

An independent study reveals a Quebec-based platform dramatically improves patient outcomes and slashes clinical workload. Is this the new OS for healthcare?

For decades, insomnia treatment meant risky sedatives. Now, a new class of drugs is revolutionizing sleep science, promising safer rest for millions.

Kardium’s landmark FDA win and a new wave of innovators signal a biotech boom, cementing British Columbia's status as a global hub for health innovation.

A new initiative promises to help rural clinics access federal funds for telehealth, but it’s also a savvy growth play for the tech company behind it.

A new study of 100M insurance claims reveals a shocking failure: nearly 9 in 10 women in some states get no osteoporosis care after a fracture. Why?

For years, CIDP patients faced limited options. Now, a wave of targeted therapies promises to transform treatment, sparking a multi-billion dollar market boom.

A silent health crisis affecting a billion women is becoming a major economic focus. One firm's move to train a new workforce signals a paradigm shift.

With its 10th acquisition and a fresh $40M, Connie Health is using its AI platform to rapidly scale and become a key partner in value-based care.

A new drug from Cambrian Bio shows promise in activating a key metabolic switch. This could lead to treatments that burn fat while preserving muscle mass.

Beyond the ribbon-cutting, Healthconnect Texas's new hub is the physical anchor for an ambitious plan to merge clinical and social data, reshaping care for 27M.

Dr. Glenn Parker's recent award is more than a trophy. It's a signal of a quiet revolution in healthcare—one that uses fintech to build national resilience.

A Taipei delegation at BIO 2026 signals Taiwan's strategic pivot from manufacturing to R&D, seeking global partners for its late-stage drugs and platforms.

With a strategic CAD$2.4M investment from Securian Canada, June Health is set to redefine employer benefits by merging AI with human-centric women's care.

At BIO 2026, Transpire Bio isn't just presenting; it's pitching a new paradigm for medicine, using inhalation to tackle everything from diabetes to cancer.

A landmark partnership aims to bring data-driven transparency to senior care, combining industry ratings with a national PR campaign to redefine quality.

GSK and Spero Therapeutics have won FDA approval for Utebzi, the first oral carbapenem for complex UTIs, a move that could slash healthcare costs.